Pharmacokinetic and pharmacodynamic characterization of gepotidacin against Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh infection model
Antimicrobial Agents and Chemotherapy · 2026
DOI: 10.1128/aac.01176-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Christine M Singley und 2 weiteren Autor:innen. Beteiligte Einrichtung: GSK, Collegeville, Pennsylvania, USA. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Escherichia coli, Anti-Bacterial Agents, Klebsiella Infections. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gepotidacin is a novel first-in-class triazaacenaphthylene antibiotic developed for the treatment of uncomplicated gonorrhea and uncomplicated urinary tract infections (uUTIs). To support uUTI, in vivo pharmacokinetics (PK)/pharmacodynamics (PD) studies have been conducted in the murine neutropenic thigh infection model evaluating gepotidacin against 17 isolates of Escherichia coli and 7 isolates of Klebsiella pneumoniae having MICs of 0.25 to 16 µg/mL. Exposure data were fit using a population PK model, and efficacy data were fit with an inhibitory effect sigmoid Imax model using free-drug area under the concentration-time curve (fAUC)/MIC as the primary index. The ratios associated with response were determined for each isolate, and the median fAUC/MIC (excluding strains with
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- GSK, Collegeville, Pennsylvania, USA.
ORCID-Profile: Jennifer L Hoover
Zitieren
APA
Singley, C. M., Kurumaddali, A., & Hoover, J. L. (2026). Pharmacokinetic and pharmacodynamic characterization of gepotidacin against Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh infection model. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01176-25
Vancouver
Singley CM, Kurumaddali A, Hoover JL. Pharmacokinetic and pharmacodynamic characterization of gepotidacin against Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh infection model. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01176-25
BibTeX
@article{Singley2026,
author = {Singley, Christine M and Kurumaddali, Abhinav and Hoover, Jennifer L},
title = {Pharmacokinetic and pharmacodynamic characterization of gepotidacin against Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh infection model},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
doi = {10.1128/aac.01176-25}
}
EUVIMED